research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome
Medications for PCOS don't seem to raise heart disease risk.
Search
forLearn
0 / 0 results — no results
Research
5 / 72 results 
research Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.
research Role of Sodium-Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
SGLT2 inhibitors may help manage PCOS symptoms effectively.
research PCSK9: From Nature's Loss to Patient's Gain
Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.
research Efficacy and Safety of SGLT2 Inhibitor on Insulin Resistance and Hyperglycemia in Werner Syndrome—A Case Report
Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.
Community Join
0 / 0 results — no results